Accesso libero

Clinicopathological characteristics in women with breast cancer in extreme ages in Greece: A single centre experience

INFORMAZIONI SU QUESTO ARTICOLO

Cita

Therapeutic interventions in the study population.

Extend of surgical procedure, n (%)

Lumpectomy 8 (38.10%) 5 (22.73%) 13 (30.23%) 0.1482
Quadrantectomy 4 (19.05%) 4 (18.18%) 8 (18.6%)
Simple mastectomy 2 (9.52%) 5 (22.73%) 7 (16.28%)
Modified radical mastectomy 7 (33.33%) 4 (18.18%) 11 (25.58%)
No surgery 0 4 (18.18%) 4 (9.3%)

Adjuvant therapeutic modalities, n (%)

Chemotherapy 12 (44.44%) 9 (33.33%) 21 (38.89%) 0.0593
Radiotherapy 10 (37.04%) 5 (18.52%) 15 (27.78%)
Endocrine therapy 5 (18.52%) 13 (48.15%) 18 (33.33%)

Clinicopathological characteristics of the study population.

Age group (years) P

<40 >80 Total
Histological Type, n (%)
Ductal invasive 12 (57.14%) 13 (59.09%) 25 (58.14%) 0.1472
Lobular invasive 3 (14.29%) 2 (9.09%) 5 (11.63%)
Other 6 (28.57%) 7 (31.82%) 13 (30.23%)
Tumor Size (T), n (%)
T≤ 2 cm 7 (33.33%) 9 (40.90%) 16 (37.21%) 0.7546
T > 2 cm 14 (66.67%) 13 (59.10%) 27 (62.79%)
Positive lymph nodes, n (%)
0 lymph nodes 11 (52.38%) 12 (54.54%) 23 (53.49%) 0.8948
1–3 lymph nodes 6 (28.57%) 5 (22.73%) 11 (25.58%)
≥4 lymph nodes 4 (19.05%) 5 (22.73%) 9 (20.93%)
TNM Stage, n (%)
I 4 (19.05%) 4 (18.18%) 8 (18.61%) 0.4609
II 13 (61.90%) 11 (50.00%) 24 (55.81%)
III 4 (19.05%) 7 (31.82%) 11 (25.58%)
Hormone receptor status, n (%)
ER+/PR+ 10 (47.62%) 11 (50.00%) 21 (48.84%) 0.9571
ER−/PR− 6 (28.57%) 5 (22.73%) 11 (25.58%)
ER+/PR− 3 (14.28%) 3 (13.64%) 6 (13.95%)
ER−/PR+ 2 (9.53%) 3 (13.64%) 5 (11.63%)
Histological Grade, n (%)
I 3 (14.29%) 2 (9.09%) 5 (11.63%) 0.4754
II 5 (23.81%) 9 (40.91%) 14 (32.56%)
III 13 (61.90%) 11 (50.00%) 24 (55.81%)
eISSN:
1792-362X
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology